Investigating factors that affect retinal cell injury related to glaucoma
Modulators for Retinal Ganglion Cell Injury
This study is looking at how a protein called POU6F2 affects the health of important eye cells that help us see, especially in people with glaucoma, to find new ways to protect these cells and improve treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11030766 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific transcription factor, POU6F2, influences the health of retinal ganglion cells, which are crucial for vision. By studying both mouse models and human data, the researchers aim to uncover the molecular mechanisms that lead to cell injury in glaucoma. The approach includes examining how variations in central corneal thickness relate to glaucoma risk and how POU6F2 may play a role in protecting or damaging retinal cells. Patients may benefit from insights that could lead to new treatments or preventive strategies for glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals over 60 years old who are at risk for glaucoma or have been diagnosed with the condition.
Not a fit: Patients with glaucoma who are under 21 years old or those without any risk factors for glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for preventing vision loss in glaucoma patients.
How similar studies have performed: Previous research has shown promising results in understanding the genetic factors associated with glaucoma, suggesting that this approach could yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Geisert, Eldon E — Emory University
- Study coordinator: Geisert, Eldon E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.